Head of Longevity · CUF Hospitais e Clínicas
Opening Keynote
Head of Longevity at CUF, Portugal's largest hospital group, and a Catalyst of the Stanford Center on Longevity. Former WHO Advisor, Carla has shaped global frameworks on active aging and chronic disease prevention with the European Commission and World Bank. She opens Longevity Day with a perspective on what a 100-year life demands of medicine, systems, and each of us.
Founder · Nina's Notes & Longevity Wednesdays
Sacred Plants & Longevity
Ph.D. in Pharmaceutical Sciences and serial biotech founder. Nina built an AI diagnostics company, was first hire at a Ginkgo Bioworks acquisition, and now curates Longevity Day and writes Nina's Notes — a weekly newsletter translating frontier science for serious readers. She explores the intersection of ancestral plant wisdom and modern longevity biology.
Founder · Zenerchi Health
East Meets West: TCM Wisdom & Stem Cell Science
Dr. Yi Song, raised in Beijing in a 17-generation medical family, trained in Pathology at Brown University before focusing on regenerative and holistic healing. She has operated a holistic clinic in Boston since 2004 and founded the Zenerchi Retreat in Colombia in 2018, where she offers advanced stem cell therapies. Integrating stem cell therapy, Traditional Chinese Medicine, and anti-aging treatments, Dr. Song aims to help people live longer, healthier lives.
Neuroscientist & Wim Hof Method Instructor · Champalimaud Foundation
Ancient Signals, Modern Bodies
Computational neuroscientist with a PhD and PostDoc, researching how breathwork and cold exposure modulate the nervous system as a longevity lever. A certified Wim Hof Method instructor with six years of practice and teaching, Yves brings rigorous science to techniques that have been used for centuries.
Principal · Integra
Ancient Signals, Modern Bodies
Principal at Integra. Amanda joins the panel exploring how ancient practices — breathwork, cold exposure, nervous system regulation — act as measurable longevity levers, and what modern neuroscience is finally proving about them.
Founder · Awodee
Ancient Signals, Modern Bodies
Social epidemiologist with a PhD from the London School of Hygiene & Tropical Medicine and 25 years at UNESCO, UNFPA, and WHO. Founder of Awodee, a research platform closing the data gap in African women's health. Her personal longevity journey through Qi Gong and eastern medicine runs alongside her epidemiological work — making her a rare bridge between ancestral practice and global health science.
Founder & CEO · Mu Labs
Alchemy: Breathe & Rewire
Neuroscientist specialising in brain-computer interfaces, real-time EEG, and the quantified self. Francisco leads an immersive breathwork activation guided by live neural feedback — making the invisible architecture of the nervous system legible in real time. TEDx speaker and researcher in computational neuroscience and neuroimaging.
Founder · MVMT.Studio
Movement Activations
From Division I lacrosse at Yale to winning the Latin American CrossFit regional championship, Max brings elite athletic experience and real-world coaching wisdom. With 2,000+ client sessions, he leads the movement activations that open and close Longevity Day.
Founder & CEO · Lucis
Reading Your Blood: The Biomarker Revolution
Co-founder and CEO of Lucis, a fast-growing European health platform making advanced biomarker testing accessible and actionable. Max presents the blood biomarker revolution — how reading your own biology has become the most powerful tool in personalised longevity.
R&D Director · NOVOS
The State of Longevity Medicine
Longevity researcher and R&D Director at NOVOS, focused on the molecular biology of aging. Diogo bridges academic geroscience and consumer longevity, translating decades of aging research into evidence-based interventions that can be used today.
Researcher on Aging & Asst. Professor of Immunology · i3s & NOVA Medical School
The State of Longevity Medicine
Researcher at i3s and Assistant Professor of Immunology at NOVA Medical School, Jose Pedro studies how inflammation accelerates biological aging. His work spans immune system aging, regenerative drug development, and multi-omics tools to predict inflammatory disease trajectories.
Medical Director · TejoMed
The State of Longevity Medicine
Family physician and Medical Director at TejoMed, with 11 years of clinical experience and a postgraduate in Health Administration. Luisa combines evidence-based medicine with a strong focus on patient empowerment, mental health, and women's health — bringing a frontline clinical perspective to longevity medicine.
Founder · The Miami Institute
The State of Longevity Medicine
Founder of The Miami Institute for age management medicine and former CSO of the Blue Zones Center at Miami Worldcenter. Twenty years at the intersection of longevity science, Special Economic Zone policy, and real estate — including the world's first Blue Zones-branded skyscraper.
Head of Neurodegenerative Disorders Pillar · PPD / Thermo Fisher
Design Your Longevity Protocol
Head of the Neurodegenerative Disorders Pillar at PPD/Thermo Fisher, overseeing clinical trials in dementia research. Founder of Be a Longevity Creator, Sabine designs practical longevity protocols for remote workers and corporates — translating clinical evidence into daily habits that actually stick.
Consumer Health Investor · naturalX
The LongBio Bet: Investing at the Frontier
Founder of naturalX Health Ventures, a €100M consumer healthcare fund investing at Series A and B. A serial entrepreneur turned investor, Marvin has built CPG, digital health, and e-commerce brands across Europe and the US, and now backs the founders shaping the next generation of longevity products.
Investor · naturalX & Joyance Partners
The LongBio Bet: Investing at the Frontier
Investor at naturalX and Joyance Partners, backing scientifically-validated consumer health and longevity companies. With a PhD in Neuroscience, Yang brings a rigorous science lens to early-stage investing — joining the panel on what it actually takes to build the next generation of longevity products.
Co-Founder · Healthspan Capital & LongGame Ventures
What Comes Next
Co-Founder of Healthspan Capital and LongGame Ventures, Sebastian has built four longevity biotech companies — including Cambrian Biopharma and ImmuneAGE Bio — with a combined equity value exceeding $600M. A former Oxford biochemist turned prolific company builder, he is one of the most active architects of the LongBio ecosystem.
Research Fellow · National University of Singapore
The Thalion Initiative: Funding Radical Longevity
Research Fellow at the National University of Singapore and Scientific Director of The Thalion Initiative, Max applies theoretical physics and AI to decode the fundamental structure of aging. Inventor of lipid-based aging clocks, he argues that the next longevity breakthroughs require not more data, but better questions — and new paradigms to ask them.
Postdoctoral Researcher · Institut des Neurosciences Paris-Saclay
Beyond the Brain: Artificial Consciousness
Postdoctoral researcher in theoretical and computational neuroscience at Institut des Neurosciences Paris-Saclay. Borjan mathematically models the effects of psychedelics and brain stimulation on conscious experience, working at the precise boundary where biological intelligence meets artificial systems — and asking what it means for the mind to persist.
Research Director · LEV Foundation
DeSci & the Longevity Revolution
Research Director and Founding Board Member of the LEV Foundation. Caitlin began at SENS Research Foundation developing engineered mitochondrial genes for therapeutic allotopic expression, and now maps the entire longevity field — identifying neglected targets and building new paths to radical life extension.
CEO · ARTAN Bio
ARTAN Bio: The First Tokenized Longevity Company
CEO of ARTAN Bio, with 15 years co-founding and scaling biotechnology companies, achieving FDA approval, and holding patents on cancer therapeutics. Anthony presents ARTAN's longevity pipeline and joins the DeSci panel on decentralised models for funding radical science.
Founder & Managing Partner · Fronteava
DeSci & the Longevity Revolution
Founder and Managing Partner of Fronteava, Michelangelo helps early-stage longevity biotech and frontier science companies build their first commercial traction. His work sits at the intersection of longevity science, web3-enabled research infrastructure, and new institutional models — including charter cities. Previously strategy consulting at Bain & Company.
Co-founder · CUDIS.xyz
DeSci & the Longevity Revolution
Lizzie is co-founder of CUDIS, a smart ring company at the intersection of AI, wearables, and decentralized infrastructure. Since launching in April 2024, CUDIS has sold 15,000 rings, generated $4M in revenue, and built a community of over 100,000 members — built on the conviction that people should own their health data. She is also Vice President of the French-Chinese Blockchain Association (AFCB), a Lyon-founded community connecting builders and innovators across European and Chinese Web3 ecosystems.